Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to make cancer cells stop dividing
so they stop growing or die. Combining chemotherapy with corticosteroids may be an effective
treatment for prostate cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of methylprednisolone with
or without doxorubicin in treating patients who have metastatic prostate cancer that has not
responded to hormone therapy.